MAMaliha Asghar Alikhan

Maliha Asghar Alikhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maliha Asghar Alikhan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Inflammasomes in the Kidney

    by Holly L. Hutton, Maliha A. Alikhan, A. Richard Kitching

    Inflammasomes influence a diverse range of kidney disease, including acute and chronic kidney diseases, and those mediated by innate and adaptive immunity. Both IL-18 and in particular IL-1β are validated therapeutic targets in several kidney diseases. In addition to leukocyte-derived inflammasomes, renal tissue cells express functional inflammasome components. Furthermore, a range of endogenous substances that directly activate inflammasomes also mediate kidney injury. Many of the functional studies have focussed on the NLRP3 inflammasome, and there is also evidence for the involvement of other inflammasomes in some conditions. While, at least in some disease, the mechanistic details of the involvement of the inflammasome remain to be elucidated, therapies focussed on inflammasomes and their products have potential in treating kidney disease in the future.


  • Open Access

    Regulatory T cells in renal disease

    by Maliha A Alikhan, Megan Huynh, A Richard Kitching, Joshua D Ooi

    The kidney is vulnerable to injury, both acute and chronic from a variety of immune and metabolic insults, all of which at least to some degree involve inflammation. Regulatory T cells modulate systemic autoimmune and allogenic responses in glomerulonephritis and transplantation. Intrarenal regulatory T cells (Tregs), including those recruited to the kidney, have suppressive effects on both adaptive and innate immune cells, and probably also intrinsic kidney cells. Evidence from autoimmune glomerulonephritis implicates antigen‐specific Tregs inHLA‐mediated dominant protection, while in several human renal diseases Tregs are abnormal in number or phenotype. Experimentally, Tregs can protect the kidney from injury in a variety of renal diseases. Mechanisms of Treg recruitment to the kidney include via the chemokine receptorsCCR6 andCXCR3 and potentially, at least in innate injuryTLR9. The effects of Tregs may be context dependent, with evidence for roles for immunoregulatory roles both for endogenous Tbet‐expressing Tregs andSTAT‐3‐expressing Tregs in experimental glomerulonephritis. Most experimental work and some of the ongoing human trials in renal transplantation have focussed on unfractionated thymically derived Tregs (tTregs). However, induced Tregs (iTregs), type 1 regulatory T (Tr1) cells and in particular antigen‐specific Tregs also have therapeutic potential not only in renal transplantation, but also in other kidney diseases.


  • Open Access

    Pathogenic Role for γδ T Cells in Autoimmune Anti-Myeloperoxidase Glomerulonephritis

    by Poh-Yi Gan, Takeshi Fujita, Joshua Daniel Ooi, Maliha Asghar Alikhan, Jonathan Dick, Raymond Shim, Dragana Odobasic, Kim Maree O’sUllivan, Arthur Richard Kitching, Stephen Roger Holdsworth

    Myeloperoxidase (MPO) anti-neutrophil cytoplasmic Ab (ANCA)–associated vasculitis results from autoimmunity to MPO. IL-17A plays a critical role in generating this form of autoimmune injury but its cell of origin is uncertain. We addressed the hypothesis that IL-17A–producing γδ T cells are a nonredundant requisite in the development of MPO autoimmunity and glomerulonephritis (GN). We studied MPO-ANCA GN in wild type, αβ, or γδ T cell–deficient (C57BL/6, βTCR−/−, and δTCR−/− respectively) mice. Both T cell populations played important roles in the generation of autoimmunity to MPO and GN. Humoral autoimmunity was dependent on intact αβ T cells but was unaffected by γδ T cell deletion. Following MPO immunization, activated γδ T cells migrate to draining lymph nodes. Studies in δTCR−/− and transfer of γδ T cells to δTCR−/− mice show that γδ T cells facilitate the generation of anti-MPO autoimmunity and GN. δTCR−/− mice that received IL-17A−/− γδ T cells demonstrate that the development of anti-MPO autoimmunity and GN are dependent on γδ T cell IL-17A production. Finally, transfer of anti-MPO CD4+ T cell clones to naive δTCR−/− and wild type mice with planted glomerular MPO shows that γδ T cells are also necessary for recruitment of anti-MPO αβ CD4+ effector T cells. This study demonstrates that IL-17A produced by γδ T cells plays a critical role in the pathogenesis of MPO-ANCA GN by promoting the development of MPO-specific αβ T cells.


  • Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment

    by Maliha A. Alikhan, Shaun A. Summers, Poh Y. Gan, Amy J. Chan, Mary B. Khouri, Joshua D. Ooi, Joanna R. Ghali, Dragana Odobasic, Michael J. Hickey, A. Richard Kitching, et al.

    Toll-like receptor 9 (TLR9) enhances proinflammatory responses, but whether it can act in a regulatory capacity remains to be established. In experimental murine AKI induced by cisplatin, Tlr9−/− mice developed enhanced renal injury and exhibited fewer intrarenal regulatory T cells (Tregs) compared with genetically intact mice. A series of reconstitution and depletion studies defined a role for TLR9 in maintaining Treg-mediated homeostasis in cisplatin-induced AKI. When Rag1−/− mice were reconstituted with nonregulatory CD25− splenocytes from wild-type (WT) or Tlr9−/− mice, AKI was similarly enhanced. However, when Rag1−/− mice were reconstituted with CD4+CD25+ regulatory cells, WT CD4+CD25+ cells were more renoprotective and localized to the kidney more efficiently than Tlr9−/− CD4+CD25+ cells. In Treg-depleted Foxp3DTR mice, reconstitution with naive WT CD4+CD25+ cells resulted in less severe AKI than did reconstitution with Tlr9−/− Tregs. Tlr9−/− mice were not deficient in CD4+CD25+ cells, and WT and TLR9-deficient Tregs had similar suppressive function ex vivo. However, expression of adhesion molecules important in Treg trafficking was reduced on peripheral CD4+CD25+ cells from Tlr9−/− mice. In conclusion, we identified a pathway by which TLR9 promotes renal Treg accumulation in AKI.


  • Open Access

    Myeloperoxidase Peptide–Based Nasal Tolerance in Experimental ANCA–Associated GN

    by Poh-Yi Gan, Diana S.Y. Tan, Joshua D. Ooi, Maliha A. Alikhan, A. Richard Kitching, Stephen R. Holdsworth

    Less toxic treatment options for patients with myeloperoxidase (MPO)-ANCA–associated GN are needed. Using an established murine model of focal necrotizing GN mediated by autoimmunity to MPO (autoimmune anti–MPO GN), we assessed the capacity for nasal tolerance induced by nasal insufflation of the immunodominant nephritogenic MPO peptide (MPO409–428) to attenuate this disease. Compared with mice that received an irrelevant immunodominant ovalbumin (OVA) peptide, OVA323–339, mice that received MPO409–428 were protected from the development of humoral and cell-mediated autoimmunity to full-length MPO and the development of GN. In mice with established anti–MPO autoimmunity, nasal insufflation of MPO409–428 as a therapeutic attenuated anti–MPO GN. To investigate the nature of this induced tolerance, we isolated CD4+ T cells from the upper airway draining lymph nodes of both OVA323–339- and MPO409–428-tolerized mice. Adoptive transfer of CD4+ T cells from MPO409–428- but not OVA323–339-tolerized mice to animals with established anti–MPO autoimmunity attenuated the subsequent development of GN, confirming that the immunosuppression induced by these T cells is antigen specific. Ex vivo studies showed that nasal tolerance to MPO is mediated by both conventional and induced T regulatory cells. The strong homology between the pathogenic human MPO B cell epitope recognized by ANCA in patients with acute vasculitis and the nephritogenic murine T cell MPO epitope emphasizes the clinical relevance of this study.


  • FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis

    by Joshua D. Ooi, Poh-Yi Gan, Tong Chen, Peter J. Eggenhuizen, Janet Chang, Maliha A. Alikhan, Dragana Odobasic, Stephen R. Holdsworth, A. Richard Kitching


  • Regulatory T Cells Dynamically Regulate Selectin Ligand Function during Multiple Challenge Contact Hypersensitivity

    by Latasha D Abeynaike, James A Deane, Clare L V Westhorpe, Zachary Chow, Maliha A Alikhan, A Richard Kitching, Andrew Issekutz, Michael J Hickey

    Regulatory T cells (Tregs) play critical roles in restricting T cell–mediated inflammation. In the skin, this is dependent on expression of selectin ligands required for leukocyte rolling in dermal microvessels. However, whether there are differences in the molecules used by Tregs and proinflammatory T cells to undergo rolling in the skin remains unclear. In this study, we used spinning disk confocal microscopy in Foxp3-GFP mice to visualize rolling of endogenous Tregs in dermal postcapillary venules. Tregs underwent consistent but low-frequency rolling interactions under resting and inflamed conditions. At the early stage of the response, Treg adhesion was minimal. However, at the peak of inflammation, Tregs made up 40% of the adherent CD4+ T cell population. In a multiple challenge model of contact hypersensitivity, rolling of Tregs and conventional CD4+ T cells was mostly dependent on overlapping contributions of P- and E-selectin. However, after a second challenge, rolling of Tregs but not conventional CD4+ T cells became P-selectin independent, and Tregs showed reduced capacity to bind P-selectin. Moreover, inhibition of E-selectin at this time point resulted in exacerbation of inflammation. These findings demonstrate that in this multiple challenge model of inflammation, Treg selectin binding capacity and the molecular basis of Treg rolling can be regulated dynamically.


  • Open Access

    The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure

    by Christina V Jones, Maliha A Alikhan, Megan O’Reilly, Foula Sozo, Timothy M Williams, Richard Harding, Graham Jenkin, Sharon D Ricardo


  • Open Access

    Innate IL-17A–Producing Leukocytes Promote Acute Kidney Injury via Inflammasome and Toll-Like Receptor Activation

    by Amy J. Chan, Maliha A. Alikhan, Dragana Odobasic, Poh Y. Gan, Mary B. Khouri, Oliver M. Steinmetz, Ashley S. Mansell, A. Richard Kitching, Stephen R. Holdsworth, Shaun A. Summers


  • Open Access

    Establishing the flow cytometric assessment of myeloid cells in kidney ischemia/reperfusion injury

    by Timothy M. Williams, Andrea F. Wise, Maliha A. Alikhan, Daniel S. Layton, Sharon D. Ricardo

    Polychromatic flow cytometry is a powerful tool for assessing populations of cells in the kidney through times of homeostasis, disease and tissue remodeling. In particular, macrophages have been identified as having central roles in these three settings. However, because of the plasticity of myeloid cells it has been difficult to define a specific immunophenotype for these cells in the kidney. This study developed a gating strategy for identifying and assessing monocyte and macrophage subpopulations, along with neutrophils and epithelial cells in the healthy kidney and following ischemia/reperfusion (IR) injury in mice, using antibodies against CD45, CD11b, CD11c, Ly6C, Ly6G, F4/80, CSF‐1R (CD115), MHC class II, mannose receptor (MR or CD206), an alternatively activated macrophage marker, and the epithelial cell adhesion marker (EpCAM or CD326). Backgating analysis and assessment of autofluorescence was used to extend the knowledge of various cell types and the changes that occur in the kidney at various time‐points post‐IR injury. In addition, the impact of enzymatic digestion of kidneys on cell surface markers and cell viability was assessed. Comparisons of kidney myeloid populations were also made with those in the spleen. These results provide a useful reference for future analyses of therapies aimed at modulating inflammation and enhancing endogenous remodeling following kidney injury. © 2013 International Society for Advancement of Cytometry